NASDAQ:ABSI Absci (ABSI) Stock Price, News & Analysis $2.92 -0.03 (-1.02%) Closing price 07/30/2025 04:00 PM EasternExtended Trading$2.97 +0.05 (+1.82%) As of 06:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Absci Stock (NASDAQ:ABSI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Absci alerts:Sign Up Key Stats Today's Range$2.88▼$3.1750-Day Range$2.57▼$3.6352-Week Range$2.01▼$6.33Volume8.84 million shsAverage Volume6.15 million shsMarket Capitalization$372.48 millionP/E RatioN/ADividend YieldN/APrice Target$8.28Consensus RatingBuy Company Overview Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington. Read More Absci Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks56th Percentile Overall ScoreABSI MarketRank™: Absci scored higher than 56% of companies evaluated by MarketBeat, and ranked 485th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAbsci has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAbsci has only been the subject of 2 research reports in the past 90 days.Read more about Absci's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Absci are expected to grow in the coming year, from ($0.89) to ($0.69) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Absci is -3.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Absci is -3.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAbsci has a P/B Ratio of 1.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Absci's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted28.80% of the float of Absci has been sold short.Short Interest Ratio / Days to CoverAbsci has a short interest ratio ("days to cover") of 9.9.Change versus previous monthShort interest in Absci has recently increased by 22.99%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAbsci does not currently pay a dividend.Dividend GrowthAbsci does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted28.80% of the float of Absci has been sold short.Short Interest Ratio / Days to CoverAbsci has a short interest ratio ("days to cover") of 9.9.Change versus previous monthShort interest in Absci has recently increased by 22.99%, indicating that investor sentiment is decreasing significantly. News and Social Media3.2 / 5News Sentiment0.77 News SentimentAbsci has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.04 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Absci this week, compared to 4 articles on an average week.Search Interest18 people have searched for ABSI on MarketBeat in the last 30 days. This is an increase of 29% compared to the previous 30 days.MarketBeat Follows10 people have added Absci to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Absci insiders have bought more of their company's stock than they have sold. Specifically, they have bought $152,000.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.49% of the stock of Absci is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.05% of the stock of Absci is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Absci's insider trading history. Receive ABSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter. Email Address ABSI Stock News HeadlinesInsider Buying: Absci Corporation (NASDAQ:ABSI) Insider Purchases 50,000 Shares of StockJuly 30 at 5:20 AM | insidertrades.comAbsci Corporation to Announce Q2 2025 Financial Results and Business Updates on August 12, 2025July 30 at 4:25 PM | quiverquant.comQINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world. | Traders Agency (Ad)Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025July 30 at 4:05 PM | globenewswire.comMorgan Stanley Cuts Absci (NASDAQ:ABSI) Price Target to $6.40July 30 at 2:08 AM | americanbankingnews.comAbsci Corporation Stock (ABSI) Opinions on $50 Million Public OfferingJuly 29 at 1:12 PM | quiverquant.comQAbsci shares tumble 16% after pricing discounted stock offeringJuly 26, 2025 | msn.comIntel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market SessionJuly 25, 2025 | benzinga.comSee More Headlines ABSI Stock Analysis - Frequently Asked Questions How have ABSI shares performed this year? Absci's stock was trading at $2.62 on January 1st, 2025. Since then, ABSI stock has increased by 11.5% and is now trading at $2.92. How were Absci's earnings last quarter? Absci Corporation (NASDAQ:ABSI) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.02. The firm earned $1.18 million during the quarter, compared to analyst estimates of $1.07 million. Absci had a negative net margin of 2,232.13% and a negative trailing twelve-month return on equity of 53.69%. Read the conference call transcript. When did Absci IPO? Absci (ABSI) raised $200 million in an initial public offering (IPO) on Thursday, July 22nd 2021. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share. Who are Absci's major shareholders? Absci's top institutional shareholders include ARK Investment Management LLC (7.88%), DKM Wealth Management Inc. (0.02%) and Ethic Inc. (0.01%). Insiders that own company stock include Phoenix Venture Partners Ii Lp, Redmile Group, Llc, Zachariah Jonasson and Andreas Busch. View institutional ownership trends. How do I buy shares of Absci? Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Absci own? Based on aggregate information from My MarketBeat watchlists, some other companies that Absci investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Arista Networks (ANET) and CrowdStrike (CRWD). Company Calendar Last Earnings5/13/2025Today7/31/2025Next Earnings (Estimated)8/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryBusiness Services Current SymbolNASDAQ:ABSI CIK1672688 Webwww.absci.com Phone360-949-1041FaxN/AEmployees210Year FoundedN/APrice Target and Rating Average Price Target for Absci$8.28 High Price Target$10.00 Low Price Target$6.40 Potential Upside/Downside+183.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.92) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$103.11 million Net Margins-2,232.13% Pretax Margin-2,231.01% Return on Equity-53.69% Return on Assets-45.89% Debt Debt-to-Equity RatioN/A Current Ratio5.72 Quick Ratio5.72 Sales & Book Value Annual Sales$4.53 million Price / Sales82.22 Cash FlowN/A Price / Cash FlowN/A Book Value$1.56 per share Price / Book1.87Miscellaneous Outstanding Shares127,560,000Free Float114,178,000Market Cap$372.48 million OptionableOptionable Beta2.01 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:ABSI) was last updated on 7/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Absci Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Absci With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.